190 related articles for article (PubMed ID: 20540665)
1. Prevalence of metabolic syndrome in women with polycystic ovary syndrome, using two proposed definitions.
Bhattacharya SM
Gynecol Endocrinol; 2010 Jul; 26(7):516-20. PubMed ID: 20540665
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of metabolic syndrome in reproductive-aged polycystic ovary syndrome Thai women.
Indhavivadhana S; Wongwananuruk T; Rattanachaiyanont M; Techatraisak K; Leerasiri P; Tanmahasamut P; Popijan M
J Med Assoc Thai; 2010 Jun; 93(6):653-60. PubMed ID: 20572369
[TBL] [Abstract][Full Text] [Related]
3. Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome.
Cussons AJ; Watts GF; Burke V; Shaw JE; Zimmet PZ; Stuckey BG
Hum Reprod; 2008 Oct; 23(10):2352-8. PubMed ID: 18635531
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation criteria: a population-based study.
Bener A; Zirie M; Musallam M; Khader YS; Al-Hamaq AO
Metab Syndr Relat Disord; 2009 Jun; 7(3):221-9. PubMed ID: 19320557
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of metabolic syndrome in adults with excess of adiposity: comparison of the Adult Treatment Panel III criteria with the International Diabetes Federation definition.
González-Ortiz M; Martínez-Abundis E; Jacques-Camarena O; Hernández-González SO; Valera-González IG; Ramos-Zavala MG
Acta Diabetol; 2006 Nov; 43(3):84-6. PubMed ID: 17143786
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome in females with polycystic ovary syndrome and International Diabetes Federation criteria.
Bhattacharya SM
J Obstet Gynaecol Res; 2008 Feb; 34(1):62-6. PubMed ID: 18226131
[TBL] [Abstract][Full Text] [Related]
7. Comparison of definitions of the metabolic syndrome in adult Asian Indians.
Wasir JS; Misra A; Vikram NK; Pandey RM; Gupta R
J Assoc Physicians India; 2008 Mar; 56():158-64. PubMed ID: 18697631
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
[TBL] [Abstract][Full Text] [Related]
9. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study.
Hildrum B; Mykletun A; Hole T; Midthjell K; Dahl AA
BMC Public Health; 2007 Aug; 7():220. PubMed ID: 17727697
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions.
Zabetian A; Hadaegh F; Azizi F
Diabetes Res Clin Pract; 2007 Aug; 77(2):251-7. PubMed ID: 17234299
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of vascular disease in metabolic syndrome using three proposed definitions.
Athyros VG; Ganotakis ES; Elisaf MS; Liberopoulos EN; Goudevenos IA; Karagiannis A;
Int J Cardiol; 2007 Apr; 117(2):204-10. PubMed ID: 16854482
[TBL] [Abstract][Full Text] [Related]
12. The metabolic syndrome in young Korean women with polycystic ovary syndrome.
Park HR; Choi Y; Lee HJ; Oh JY; Hong YS; Sung YA
Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S243-6. PubMed ID: 17610984
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome.
Cheung LP; Ma RC; Lam PM; Lok IH; Haines CJ; So WY; Tong PC; Cockram CS; Chow CC; Goggins WB
Hum Reprod; 2008 Jun; 23(6):1431-8. PubMed ID: 18359783
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of the metabolic syndrome in German women with polycystic ovary syndrome.
Hahn S; Tan S; Sack S; Kimmig R; Quadbeck B; Mann K; Janssen OE
Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):130-5. PubMed ID: 17318774
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of chronic kidney disease in adults with metabolic syndrome.
Emem-Chioma PC; Siminialayi IM; Wokoma FS
Saudi J Kidney Dis Transpl; 2011 Sep; 22(5):949-54. PubMed ID: 21912024
[TBL] [Abstract][Full Text] [Related]
16. The implications of anthropometric, inflammatory and glycaemic control indices in the epidemiology of the metabolic syndrome given by different definitions: a classification analysis.
Panagiotakos DB; Pitsavos C; Das UN; Skoumas Y; Stefanadis C
Diabetes Obes Metab; 2007 Sep; 9(5):660-8. PubMed ID: 17697058
[TBL] [Abstract][Full Text] [Related]
17. IDF and ATP-III definitions of metabolic syndrome in the prediction of all-cause mortality in type 2 diabetic patients.
Monami M; Marchionni N; Masotti G; Mannucci E
Diabetes Obes Metab; 2007 May; 9(3):350-3. PubMed ID: 17391162
[TBL] [Abstract][Full Text] [Related]
18. Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program.
Boronat M; Saavedra P; Varillas VF; Wagner AM; López-Plasencia Y; Alberiche MP; Nóvoa FJ
Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):417-22. PubMed ID: 18819785
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome.
Vural B; Caliskan E; Turkoz E; Kilic T; Demirci A
Hum Reprod; 2005 Sep; 20(9):2409-13. PubMed ID: 15919774
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of metabolic syndrome estimated by International Diabetes Federation criteria in a Hungarian population.
Császár A; Kékes E; Abel T; Papp R; Kiss I; Balogh S
Blood Press; 2006; 15(2):101-6. PubMed ID: 16754273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
